Skip to content

A research study looking into how cagrilintide influences food intake and appetite in people with overweight or obesity

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524206-15-00
Enrollment
120
Registered
2026-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 3, 2026